EZH2 and Miyoshi myopathy: In line with this, selective inhibition of EZH2 (EZH2i) with UNC1999 impaired cell viability and induced apoptosis in MM cell lines and primary patient samples11, and upregulated tumour suppressor miRNAs that repress oncogenes with a vital function for MM cell growth and survival11–13.